Global Breast Cancer Screening Test Market: Latest Trends, Opportunities and Driver
According to a new report published by Reports Monitor titled, “Global Breast Cancer Screening test Market, Growth Opportunities, Innovations and Forecast, 2018-2025,”the breast cancer screening test market was valued at XX million in 2016, and is projected to reach at XX million by 2025, growing at a CAGR of XX% from 2018 to 2025.
Breast cancer screening is the method of detecting sign and symptoms of breast cancer. Detection in initial stage of the cancer can helps to increases the chances of recovery and providing appropriate treatment.
Breast cancer often detected in the women age ranging between 45-70 or geriatric population. People’s awareness in concerns with healthcare and habit of preventing precaution are boosting the growth of the breast cancer screening test market. Rising government initiative in spreading awareness of breast cancer and funding for many research organisations propels the growth of the market. However, high cost and time consuming process of MRI are some of the challenges to the market. According to the WHO, in 2012, round 1.7 million new cases of breast cancer were diagnosed globally and this number is keep on growing.
This report provides a detailed analysis of breast cancer screening test market, which includes current industry situations such as market size, growth and demands, market outlook, major players with their key strategies such as investment, mergers and acquisitions, value chain analysis and porter’s analysis. It covers the market canvas and the growth opportunities in the coming years. The report has been made with an in-depth analysis along with important inputs from the various industry experts. The research is carried out with both extensive primary and secondary data sources supported with either bottom up or top down approach.
The global breast cancer screening test market is majorly segmented on the basis of type of test and end user. Based on the type of the test, market is segmented into physical exam, laboratory test and imaging tests. On the basis of end user, market is segmented into hospitals, clinics, diagnostic centre and others
The global Breast cancer screening test market is majorly studied across four regions: North America, Europe, Asia Pacific and LAMEA (Latin America, Middle East and Africa). Rising government initiative by funding organizations to spread awareness and research on breast cancer screening drives the growth of the market. Increasing disposal income and healthcare education in developing countries are propels the growth of the market in Asia-Pacific region.
The major key players operating in the market are: GE Healthcare, Hologic Inc., Siemens Healthcare GmbH, Allengers Infotech, Carestream Health., Philips Healthcare, Shimadzu Corporation, Toshiba Medical Systems Corporation, Hitachi Medical Corporation, Esaote, Agilent Technologies and Hitachi Medical Corporation (HMC)
About Garner Insights:
We at Garner Insights.com provide a comprehensive analysis by providing in-depth reports of the various market verticals. Our Mission is to provide a detailed analysis of the vast markets worldwide backed by rich data. Decision makers can now rely on our well-defined data gathering methods to get the correct and accurate market forecasting along with detailed analysis.